Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Thx to whoever posted BCON heads-up a few weeks ago!!!!$$$$
BCON +25% (.93)
Beacon Power Affirms Strong Support for $4-Billion Federal Government Energy Storage and Smart Grid Initiatives
Last update: 4/29/2009 10:16:00 AM
Company Plans to Pursue Energy Storage Project Funding Opportunities Through U.S. Department of Energy Technology Development Grants TYNGSBORO, Mass.,
Apr 29, 2009 (BUSINESS WIRE) -- Beacon Power Corporation (BCON), a company that designs and develops advanced products and services to support more stable, reliable and efficient electricity grid operation, announced its full support for the U.S. Department of Energy's (DOE) new smart grid technology development project funding programs. The program plans were announced on April 16, 2009, by Vice President Joe Biden and Commerce Secretary Gary Locke. The Vice President outlined plans to distribute grants for smart grid technology development ($3.3 billion) and for smart grid storage, monitoring and technology viability (an additional $615 million). As part of Vice President Biden's announcement, the DOE released a draft Funding Opportunity Announcement (FOA) for a smart grid regional demonstration initiative. Beacon Power has reviewed the initial FOA and plans to apply for one or more grants to support deployment of the Company's energy storage technology for grid frequency regulation. "We're very pleased that the Obama administration and DOE have determined that energy storage and smart grid technologies merit funding support to demonstrate the benefits their implementation will bring to our nation's power grid," said Bill Capp, Beacon president and CEO. "It's very encouraging that flywheels have been specifically recognized as a candidate technology in the draft Funding Opportunity Announcement." "We are reviewing the relevant energy storage project opportunities," Capp continued, "and we look forward to the details being finalized by DOE. We then expect to submit one or more grant proposals which, if successful, will help Beacon demonstrate how our flywheel technology can provide utility-scale frequency regulation service cleanly and efficiently, and in accordance with federal smart grid requirements." The draft FOA includes proposed funding for one or two energy storage demonstration projects for grid frequency regulation. The proposed total funding to be made available for the project(s) is $40-50 million, on a 50% applicant cost-share basis. The DOE has not yet announced a schedule for finalizing the FOA, or for submission deadlines or award announcements. In addition to and separate from this new funding opportunity from the federal government, Beacon Power and DOE are in the final due diligence stage of the Company's application for a loan guarantee. The loan guarantee, if approved and successfully negotiated, could lead to funding for a large majority of the cost of Beacon's proposed 20-megawatt flywheel frequency regulation plant in Stephentown, New York. The proposed new DOE grant funding opportunities described above are additive to Beacon's loan guarantee application - that is, Beacon has the potential to be awarded both a loan guarantee and one or more co-funding grants under the new DOE initiative.
PGYC $255 Million Agreement & Acquisition news
10:00a ET April 29, 2009 (Market Wire)
Patriot Energy Corporation (PINKSHEETS: PGYC) announced today that it has concluded a distribution agreement with Toshent Overseas valued at $255 million USD, further to the previously announced letter of intent and memorandum of understanding.
According to the Distribution agreement and initial purchase order, Toshent Overseas will purchase and distribute the H2O device in the Russian marketplace and Eurasia on a non-exclusive but preferential basis. Toshent will purchase 12,500 units per month minimum (150,000 per year) for a period of 5 years, representing unit sales of $187.5 million and 67.5 million in recurring revenues.
The consolidated distribution agreement and purchase orders on hand represent over $340 million in revenue for the company over the next 5-years.
The company is planning to provide a letter to shareholders tomorrow to outline the steps taken or to be taken to conclude the sale of the company as well as answer common questions and inquiries. The letter will be sent by email to shareholders that have registered on the company's website and it will also be available for download on the website.
Oliver Stone To Direct 'Wall Street' SequelLast update: 4/29/2009 9:42:31 AMLOS ANGELES (AFP)--Oliver Stone and Michael Douglas have signed on to direct and star in a sequel to "Wall Street," the hit 1987 film charting corporate greed and excess, it was reported Wednesday. The Hollywood Reporter said Stone has now confirmed he will make the long-mooted follow-up, which will revolve around corporate raider Gordon Gecko, a role which earned Douglas a best actor Oscar. Plot details about the new film are sketchy but previous reports have said the film would be set in the hedge fund era. "Transformers" star Shia LaBeouf will play a young worker trying to forge a career in finance. Stone has a history for making provocative films and most recently directed "W" the biopic about former President George W. Bush and prior to that "World Trade Center" about the Sept. 11, 2001 attacks on New York. Although "Wall Street" found only modest success at the box office when it first came out, it went on to find a cult following in the financial world, especially for Gekko's quips such as "lunch is for wimps" and "greed is good."
Cyberlux Launches WhiteEye Products to Address Existing Military, Law Enforcement, First Responder and Commercial Lighting MarketsLast update: 4/28/2009 9:22:02 AMWhiteEye Products Utilize Advanced Military-grade Lighting Technology; Fulfillment Begins of Initial Law Enforcement WhiteEye Orders RESEARCH TRIANGLE PARK, N.C., Apr 28, 2009 (BUSINESS WIRE) -- Cyberlux Corporation (OTCBB: CYBL), a leading provider of LED lighting solutions, announced today that the company has introduced a new line of portable lighting systems, the WhiteEye Tactical Illumination Systems, that will address the large opportunities for white-only portable lighting in the military, law enforcement, first responder and commercial markets. To capture these opportunities, Cyberlux has incorporated the advanced capabilities of its military-grade BrightEye LED lighting technology into a white-only, visible lighting product line for existing Department of Defense (DOD), Federal, state and local governments and commercial customers. One of the first customers is the Lewiston Police Department of Lewiston, New York, which recently ordered 3 Systems for general law enforcement use for checkpoints, crime scene investigation and first response lighting. The Cyberlux WhiteEye Tactical Illumination System products deliver the most energy efficient white LED lighting for portable broad area illumination now commercially available. Engineered to provide ideal illumination for tactical and emergency response situations, Cyberlux has designed the WhiteEye configurations to flexibly illuminate any location or environment requiring rapid setup, light-weight portability or extended battery operation, where electrical power is unavailable. The Cyberlux WhiteEye Tactical Illumination Systems are available for general white, visible lighting applications and have the following operational characteristics: -- Super-Bright White Tactical Lighting System -- Directed White Illumination on Target Area over 1000 feet -- Over 6,000 Lumens per Lighthead for Broad Area Lighting -- Highly Portable for Rapid Deployment Lighting Applications -- 2CP0210 Dual Lighthead Tactical Lighting System: -- 2 Quadpods, 2 Light Heads, 2 Li-Ion Batteries -- Self-Contained System Case / Weight: 77 lbs -- Single Battery Charger -- Standard Configuration Run Time (1 Li-Ion Battery) -- Low: 16 hours -- Medium: 8 hours -- High Intensity: 3 hours -- Extended Battery Kit Available to Double Run Time -- Each Lighthead operates on 1 Standard UBI-2590 Li-Ion Battery -- Wireless System Control and Operation -- Performs for over 50,000 hours without a lighting element replacement -- System is more than 37% more energy efficiency compared to traditional lighting -- Solar System configuration available -- 2CP0209 Single Lighthead system also available "The WhiteEye Tactical Illumination System product line is an expansion of our successful BrightEye products intended for customers who only require white, visible lighting. The customer response to the WhiteEye has been fantastic, and we see a significant new set of revenue opportunities, not only with our existing customer base but also with the Federal, state and local law enforcement markets. With law enforcement customers ranging from Lewiston, New York to Federal agencies, our WhiteEye lighting systems are well positioned to be a leading product solution for customers who require significant lighting capability in a rugged, light-weight, portable package," said Mark Schmidt, president and chief executive officer of Cyberlux. "We look forward to having our new WhiteEye Tactical Illumination System products become the products of choice to replace existing incandescent-based portable lighting capabilities." The Cyberlux WhiteEye Tactical Illumination Systems are specifically designed to provide energy efficient, white LED lighting for general portable lighting applications. With patent-pending designs and technology, these Cyberlux products provide ideal visible illumination for any DoD, Federal, state and local government, and commercial opportunities requiring high-performance visible lighting capability in a light-weight, highly portable package. About Cyberlux Corporation Cyberlux Corporation (OTC Bulletin Board: CYBL), a leader in solid-state lighting innovation, has developed breakthrough LED lighting technology that provides the most energy efficient and cost effective portable lighting solutions available today for military and commercial uses. The Military and Homeland Security products provide tactical covert and visible lighting capability and are designed as highly mobile, battery-powered lighting systems ideal for threat detection, force and asset protection and general expeditionary lighting needs. For more information, please visit .
Anybody on QEDN conf call?
Patriot Energy Moves to an LOI With Toshent Overseas
9:51a ET April 22, 2009 (Market Wire)
Patriot Energy Corporation (PINKSHEETS: PGYC) announced today that they have signed a letter of intent with Toshent Overseas for the purchase and distribution of the H2O Injectors.
According to the LOI, Toshent Overseas will purchase and distribute the H2O device in the Russian marketplace and Eurasia on a non-exclusive but preferential basis. The companies have now set the number of device to be delivered to 12,500 units per month minimum (150,000 per year) as oppose to the previously mentioned 100,000 yearly units. The company expects to receive a purchase order on or before April 29, 2009.
This potential order consolidated with the previous order from TI Innovation, would represents total revenues in excess of $340 million over the next 5 years.
GRDO joint marketing venture
Guard Dog ID, LLC and National Search Directory Announce Joint Marketing VentureLast update: 4/20/2009 3:04:00 PMRENO, Nev., Apr 20, 2009 (BUSINESS WIRE) -- Guard Dog, Inc. (Pink Sheets:GRDO) announced earlier today that Guard Dog ID, LLC, has entered a joint marketing venture with National Search Directory, Inc. According to James Watson, President and CEO of Guard Dog, "The relationship created between Guard Dog ID, LLC and NSD will allow Guard Dog to receive national marketing for little to no upfront cost and to increase its revenue by receiving percentages of multiple subscription agreements offered by the NSD network." (NSD). Nation Search Directory Inc. is currently a privately held corporation that manages three core marketing platforms designed to provide businesses with a cost effective method to market products and services on local and national levels. Through National Savings Directory and National Sweepstakes Directory, NSD will utilize multi-tiered marketing platforms to promote online exposure of client products and services and LEC (Local Exchange Carrier) billing to simplify the transaction process. National Savings Directory, Inc., will market Guard Dog ID, LLC services for little to no upfront cost plus a percentage of the net profits generated by the NSD platforms. Guard Dog ID, LLC will allow NSD to market Guard Dog Identity Theft Protection Services at a discount to various marketing network's and specialty groups for no upfront costs and a percentage of the Guard Dog ID, LLC net profits generated by the NSD Platforms. Additionally NSD will share residual subscription revenues with Guard Dog ID, LLC for marketing the NSD platforms. In the weeks to come NSD will begin promoting Guard Dog identity theft protection services through a customer referral contest hosted on a rewards mall offered by the National Savings Directory. This promotion will allow members to receive savings, earn reward points and prizes. The NSD Network will continue to provide extensive marketing support of Guard Dog, ID LLC, while publicizing additional sweepstakes and contests.
Jumped in at 5.20 when news broke :)
MGM climbing +12%
Sprint Receives $7.3 Million U.S. Department of Energy Grant to Expand Hydrogen Fuel Cell Deployment
Patriot Energy Files Disclosure Documents
9:02a ET April 16, 2009 (Market Wire)
Patriot Energy Corporation (PINKSHEETS: PGYC) filed its initial disclosure documents through www.Pinksheets.com.
According to the company, the filing of the initial disclosure statement will enable the company to become fully compliant with the OTC Pinksheets market. The disclosure documents will be available for review by shareholders within the next 48 hours and include information on the stock purchase offer.
"All our positive activities have delayed some of our filings with Pinksheets and we are doing everything to keep up with our very important ongoing business activities as well as dealing with the transaction at hand." Said Mr. Tony Bisante, President of Patriot Energy Corp. "We continue to forge forward with our sales and distribution efforts as well as the immediate value creation derived from the sale of the company at a significant premium" further added Bisante.
Cell Therapeutics Announces Single Institutional Investor Purchases $15 Million of Preferred Stock
2:54p ET April 13, 2009 (PR NewsWire)
Cell Therapeutics, Inc. (Nasdaq and MTA: CTIC) today announced that it has agreed to sell up to $20 million of Series 1 Preferred Stock and warrants in a registered offering to a single institutional investor. The investor initially purchased today, for $15 million cash, shares of Series 1 Preferred Stock with a stated value of $15 million and certain associated common stock warrants and has the right to, within 60 days, purchase for an additional $5 million cash additional shares of Series 1 Preferred Stock with a stated value of $5 million with no additional warrants. The Series 1 Preferred Stock is convertible into shares of common stock at a conversion price of $0.30. The investor received 45% warrant coverage on the initial $15 million purchase. The warrants have an exercise price of $0.41 per share, for total potential additional proceeds of approximately $9 million. Approximately three-fifths of the warrants cannot be exercised until after six months from issuance, or 61 days from issuance if the investor does not exercise its option to purchase the additional Series 1 Preferred Stock.
The Series 1 Preferred Stock is non-dividend bearing and has no voting rights except to the extent required by law.
Separately, the Company reacquired the remaining 100 outstanding shares ($100,000 stated value) of its Series A 3% Convertible Preferred Stock in exchange for 288,517 shares of common stock, and the Company has agreed to reacquire the remaining 1,000 outstanding shares ($1,000,000 stated value) of its Series D 7% Preferred Stock in exchange for shares of common stock based on a formula keyed to the volume-weighted average price over a 3-day period following April 13, 2009.
Upon completion of these exchanges, the only preferred stock of the Company outstanding will be the new Series 1 Preferred Stock, thereby relieving the Company of future potential redemptions and restrictive covenants contained in the prior series of Preferred Stock.
CTIC news out
more CYBL news
CYTX --- sorry
CTYX Receives U.S. Patent Allowance for Key Commercial Products
LYV TKTM merger
Noted HDVY late yesterday - sounds like a winner
CYCC news today - more pre-NDA biotechno babble
HDVY will receive payments, royalties and additional undisclosed financial considerations from Quest Diag. Might be hot tomorrow..
CTIC News: Exchanges 83% of Remaining Convertible Preferred Stock Into New Non-dividend Bearing, Non-redeemable Convertible Preferred Stock With Conversion Price of $0.14 per ShareLast update: 2/5/2009 1:30:00 AMSEATTLE, Feb 05, 2009 /PRNewswire-FirstCall via COMTEX/ -- Cell Therapeutics (CTI) (Nasdaq and MTA: CTIC) announced today that it has issued 6,634 shares of Series F Preferred Stock in exchange for 6,634 shares of CTI's Series A, B and C Convertible Preferred Stock. The exchange constitutes 83% in interest of all series of CTI's Convertible Preferred Stock. Each share of the new Preferred Stock will become convertible into 7,143 shares of CTI's common stock, at a conversion price of $0.14 per common share representing a significant premium to the current market price. The Series F Preferred Stock cannot become convertible into common stock sooner than April 1, 2009. Additionally, the Company has the ability to redeem all, but not less than all, of the outstanding Series F Preferred Stock for cash when the Volume-Weighted Average Price (VWAP) has exceeded $0.28 for ten previous trading days. The Series F Preferred Stock does not provide a redemption right for the holders as did the Series A, B and C Convertible Preferred Stock, thereby eliminating the possibility that the Company could be required to make involuntary cash redemption payments of approximately $6.6 million on the preferred stock that was exchanged. The Series F Preferred Stock does not bear a fixed dividend rate. "We are pleased that almost all of the remaining preferred shareholders were willing to trade in their securities and enable CTI to avoid their redemption rights and dividend payments, saving the company approximately $6.6 million over the next 6 months, for a meaningful equity position in the Company upon their conversion into common stock," noted James A. Bianco, M.D., CEO of CTI. "With the prospects for three drug approvals in 2009, we believe they chose to participate based on the price appreciation potential of CTI should we be successful with the approvals this year."
MTL !
Heard CYCC presenting good news next week
PWAV ahead of earnings on Thurs - back to $1 perhaps (like AIG but in the different direction)
AIG 1.01 OMG - rearranging deck chairs on the titanic
Some CTIC news - Zevalin update
Treatment with the Zevalin(R) Therapeutic Regimen as Sole Therapy Produces 83 Percent Complete Response Rate in Mucosa-Associated Lymphoid Tissue (MALT) Orbital LymphomaLast update: 1/22/2009 1:30:00 AMSEATTLE, Jan 22, 2009 /PRNewswire-FirstCall via COMTEX/ -- Cell Therapeutics, Inc. (CTI) (Nasdaq and MTA: CTIC) announced today results of a study published by Esmaeli, et al. online on January 15, 2009 in the Annals of Oncology demonstrating that rituximab followed by single agent Zevalin (ibritumomab tiuxetan) in a front-line setting for patients with MALT lymphoma and low- grade follicular lymphoma that primarily involved the conjunctiva or orbit produced a complete response rate of 83 percent.
JPM, AAPL, BAC sweet !!!!$$$$
...and CNBC doomsayers make matters even worse imo
So much for that rally. Fed officials please shut up for a few days.
If I avg my AIG cost basis down again, someone should kill me. Sick stock, sick company, I think at least Q2 before divestitures start helping.
NOOOOOO - Prepare to hang thyself. AIG=PAIN
Big board bottom feeders: TITN, MTL, LEN, AOB, CADX, CEDC, LAVA, SIRI (Get ready for nice moves based on past rally)
Audiovox Distribution Pact With Sirius XM Radio
THMR news coming... Obama Camp To Change Bankruptcy Laws To Help Homeowners-Summers
thx..holding .13's for awhile waiting for break
Any further commentary on CTIC? Good, bad or otherwise...
Any thoughts on CTIC with transfer to NAS cap market?
Cell Therapeutics Announces Receipt of NASDAQ Panel Decision to Transfer to NASDAQ Capital MarketLast update: 1/7/2009 1:30:00 AMSEATTLE, Jan 07, 2009 /PRNewswire-FirstCall via COMTEX/ -- Cell Therapeutics, Inc. (CTI) (Nasdaq and MTA: CTIC) announced today that it has received notification that the NASDAQ Listing Qualifications Panel has granted CTI's request to transfer the listing of its common stock from The NASDAQ Global Market to The NASDAQ Capital Market, which will be effective with the open of trading on Thursday, January 8, 2009. CTI's shares will continue to trade under the ticker symbol CTIC. CTI's continued listing on The NASDAQ Capital Market is subject to CTI evidencing compliance with all applicable requirements for continued listing on The NASDAQ Capital Market, including the $35 million market value of listed securities requirement or its alternatives, as set forth in NASDAQ Marketplace Rule 4310(c)(3), by February 12, 2009. The Company expects to comply with all applicable requirements for continued listing on The NASDAQ Capital Market by February 12, 2009; however, there can be no assurance that it will be able to do so. As disclosed on September 6 and October 10, 2008, CTI was previously notified by NASDAQ regarding its non-compliance with the $50 million market value of listed securities requirement for continued listing on The NASDAQ Global Market. In response, CTI appeared before the NASDAQ Listing Qualifications Panel at a hearing at which it requested the transfer of its listing to The NASDAQ Capital Market pursuant to its plan to evidence compliance with the $35 million market value of listed securities requirement for continued listing on that market. The NASDAQ Capital Market is one of the three market tier designations for NASDAQ-listed stocks and operates in substantially the same manner as The NASDAQ Global Market. Securities listed on The NASDAQ Capital Market must satisfy all applicable qualification requirements for NASDAQ securities, and companies listed on The NASDAQ Capital Market must meet certain financial requirements and adhere to NASDAQ's corporate governance standards. About Cell Therapeutics, Inc. Headquartered in Seattle, CTI is a biopharmaceutical company committed to developing an integrated portfolio of oncology products aimed at making cancer more treatable. For additional information, please visit .
Most annoying trade of the week. Should have moved out when it hit .25/.27 a few days ago. Too boring for me - need volatility.